The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
An unknown quantity—The worldwide prevalence of epilepsy
Abstract
Summary: The reported incidence (rate of new cases in a population) of epilepsy is consistently lower in high‐income than in lower‐income economies, whereas opinions vary regarding comparative prevalence rates (proportion of the population with epilepsy). For any condition that does not influence mortality, lifetime prevalence should approximate to the cumulative incidence. We suspected that epilepsy prevalence might be uniform throughout the world, whereas incidence is higher in resource‐poor countries. To test whether our suspicion was reasonable, we conducted a Medline search to estimate the prevalence of active and lifetime epilepsy in different economic areas throughout the world. We found that the range of estimated prevalence of epilepsy may be broadly similar throughout the world, but comparison is limited by lack of door‐to‐door studies in high‐income economies and by variations in the definitions of active epilepsy. We contend that any inconsistencies between incidence and prevalence are due largely to the excess premature death rate in people with epilepsy in lower‐income economies. Much of the variability in epidemiologic indices arises from differences in study methodology, definitions, and risk factors. The epidemiology of epilepsy, and particularly its mortality, needs thorough investigation using uniform definitions that do not include antiepileptic drug use; causes of death should be identified and actions, including treatment and education, should be taken to avoid preventable deaths. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447
Self-citationSystematic review of the prevalence and incidence of Parkinson's disease in Asia
Muangpaisan, W., Hori, H., & Brayne, C. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20081034 · Cited by 185
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Self-citationStructural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
Whelan, C. D., Altmann, A., Botía, J. A., Jahanshad, N., Hibar, D. P., Absil, J., Alhusaini, S., Alvim, M. K. M., Auvinen, P., Bartolini, E., et al. (2018) · Brain · doi:10.1093/brain/awx341 · Cited by 531
The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review
Silva dos Santos, J., Gonçalves Cirino, J. P., de Oliveira Carvalho, P., & Ortega, M. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565700 · Cited by 254
Metadata
- Authors
- Bell, G. S., Neligan, A., & Sander, J. W.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2014-06-25
- Volume
- 55
- Issue
- 7
- Pages
- 958-962
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2034566726
- Cited by
- 180
- References
- 3
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An unknown quantity—The worldwide prevalence of epilepsy. https://app.cochat.ai/papers/10.1111/epi.12605
- The paper
- Bell, G. S., Neligan, A., & Sander, J. W. (2014). An unknown quantity—The worldwide prevalence of epilepsy. Epilepsia. https://doi.org/10.1111/epi.12605
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.